콘텐츠로 건너뛰기
Merck
모든 사진(1)

Key Documents

SRP6316

Sigma-Aldrich

Antithrombin III from human plasma

≥95% (SDS-PAGE)

동의어(들):

SERPINC1

로그인조직 및 계약 가격 보기


About This Item

UNSPSC 코드:
12352202
NACRES:
NA.32

생물학적 소스

human

분석

≥95% (SDS-PAGE)

형태

lyophilized

분자량

58 kDa

포장

pkg of 100 μg
pkg of 500 μg

UniProt 수납 번호

배송 상태

wet ice

저장 온도

−20°C

유전자 정보

human ... SERPINC1(462)

일반 설명

SerpinC1, also known as antithrombin III (AT III), is a member of the serpin superfamily of serine protease inhibitors. The gene is mapped to human chromosome 1. SerpinC1 is a glycoprotein with three β-sheets and nine α-helices. The protein has an active site region and a heparin binding site.

생화학적/생리학적 작용

SerpinC1, also known as antithrombin III (AT III), has been found to be a marker for disseminated intravascular coagulation (DIC) and to be of prognostic significance in septic patients. Antithrombin III synthesized in the liver is the principal plasma serpin of blood coagulation proteases and inhibits thrombin and other factors such as Xa by the formation of covalently linked complexes. Thus, it is one of the most important coagulation inhibitors and the fundamental enzyme for the therapeutical action of heparin. The inhibitory activity of AT III undergoes a dramatic increase in the presence of heparin and other glycosaminoglycans. Antithrombin III mediates the promotion of prostaglandin release, an inhibitor of leucocyte activation and downregulation of many proinflammatory cytokines. It exerts anti-inflammatory properties in addition to its anti-coagulative mechanisms. The deficiency or functional abnormality of AT III may result in an increased risk of thromboembolic disease, such as deep vein thrombosis and pulmonary embolism. In addition, it has been reported that AT III can alter or influence inflammatory processes via inhibition of NF (nuclear factor)-κB activation or actin polymerization. It is found in normal serum at 15mg/100mL. Found at higher levels in plasma than in serum because of complexing with thrombin during coagulation. Clinically, reduced levels are indicative of hypercoagulability. Reduction in the levels of antithrombin III enhances the severity of renal ischemia/reperfusion injury.

물리적 형태

Lyophilized from 50 mM Tris-HCl, pH 8.0, with 150 mM NaCl.

재구성

In water or aqueous buffer

Storage Class Code

13 - Non Combustible Solids

WGK

nwg


시험 성적서(COA)

제품의 로트/배치 번호를 입력하여 시험 성적서(COA)을 검색하십시오. 로트 및 배치 번호는 제품 라벨에 있는 ‘로트’ 또는 ‘배치’라는 용어 뒤에서 찾을 수 있습니다.

이 제품을 이미 가지고 계십니까?

문서 라이브러리에서 최근에 구매한 제품에 대한 문서를 찾아보세요.

문서 라이브러리 방문

Plasma antithrombin III and thrombin generation time: correlation with hemoglobin A1 and fasting serum glucose in young diabetic women.
Sowers JR, et al.
Diabetes Care, 3, 655-658 (1980)
The anti-inflammatory properties of antithrombin III: new therapeutic implications.
Okajima K and Uchiba M
Seminars in Thrombosis and Hemostasis, 24, 27-32 (1998)
Antithrombin III supplementation in severe sepsis: beneficial effects on organ dysfunction.
Inthorn D, et al.
Shock, 8, 328-334 (1997)
Laboratory tests for antithrombin deficiency.
Khor B and Van Cott EM
American Journal of Hematology, 85, 947-950 (2010)
Antithrombin III inhibits nuclear factor kappaB activation in human monocytes and vascular endothelial cells.
Oelschlager C, et al.
Blood, 99, 4015-4020 (2002)

자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..

고객지원팀으로 연락바랍니다.